Updated: February 5, 2026
Haloette Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- Current Haloette Shortage Status (2026)
- Why Patients Experience Stock-Outs Even Without a Declared Shortage
- A Brief History of Etonogestrel/Ethinyl Estradiol Ring Availability
- What Should Patients Do If They Can't Find Haloette?
- Will Haloette Get Easier to Find Over Time?
- Key Takeaways for Haloette Patients in 2026
Is Haloette in a shortage? Get the latest 2026 update on Haloette availability, what's causing stock gaps, and what patients should do right now.
If you've been searching for Haloette at your pharmacy and coming up empty, you may be wondering: Is there a shortage? This article gives you the current status as of 2026 and tells you exactly what to do if your pharmacy is out of stock.
Current Haloette Shortage Status (2026)
As of 2026, Haloette (etonogestrel/ethinyl estradiol vaginal ring) is NOT listed on the FDA Drug Shortages Database or the American Society of Health-System Pharmacists (ASHP) shortage list. There is no declared national or manufacturer-level shortage of Haloette or the other etonogestrel/ethinyl estradiol vaginal ring generics.
However — and this is important — the absence of a declared shortage does not mean every pharmacy has it on the shelf. Localized stock-outs at individual pharmacy locations happen regularly for reasons unrelated to a manufacturer crisis.
Why Patients Experience Stock-Outs Even Without a Declared Shortage
Haloette is a relatively newer market entrant (FDA-approved in 2022) that competes on pharmacy shelves with EluRyng and EnilloRing — two other generic versions of NuvaRing approved since 2019. Pharmacies make stocking decisions based on their wholesaler relationships, insurance plan formularies, and local demand patterns. This can lead to situations where:
A pharmacy stocks EluRyng but not Haloette (or vice versa)
A pharmacy runs out and its next delivery is several days away
Insurance formulary changes have shifted demand to Haloette at pharmacies that hadn't stocked it previously
Small or rural pharmacies simply don't order vaginal ring contraceptives regularly due to low demand
A Brief History of Etonogestrel/Ethinyl Estradiol Ring Availability
NuvaRing received FDA approval in 2001 and for nearly two decades was the only vaginal ring contraceptive of its kind. During that period, any supply disruption affected all ring users. In 2019, EluRyng became the first FDA-approved generic of NuvaRing, significantly expanding supply. In 2022, Haloette (by Mayne Pharma, manufactured by Mithra) and EnilloRing joined the market, further diversifying the supply chain.
Today, having three FDA-approved generics and the original brand gives patients more options than ever before. The practical challenge is that pharmacies stock only some of these products, and individual stock-outs happen even when overall supply is healthy.
What Should Patients Do If They Can't Find Haloette?
Here's a practical action plan for 2026:
Check the FDA shortage database directly: Visit fda.gov and search "etonogestrel" or "ethinyl estradiol vaginal ring" to verify current shortage status before assuming there's a supply crisis.
Use medfinder: Visit medfinder.com to have pharmacies near you called on your behalf. Results are texted to you directly.
Ask about bioequivalent alternatives: EluRyng and EnilloRing are identical in active ingredients and dosing to Haloette. Ask your pharmacist if they have either in stock, and ask your provider to authorize a substitution.
Request an order: If your pharmacy is temporarily out, ask them to place an order from their wholesaler. Most pharmacies can receive stock within 1–2 business days.
Consider mail-order: Mail-order pharmacies and telehealth services (Nurx, The Pill Club, Wisp) often carry consistent stock and can ship Haloette or a generic equivalent to your door.
Will Haloette Get Easier to Find Over Time?
Yes, trends suggest this will improve. As insurers increasingly add Haloette to their preferred formularies at $0 copay, pharmacies will respond by stocking it more consistently. The expanded generic market overall increases supply chain resilience. In the meantime, knowing your alternatives — and using tools like medfinder — is the best strategy.
Key Takeaways for Haloette Patients in 2026
No declared national shortage of Haloette as of 2026
Localized stock-outs happen due to stocking decisions, not a manufacturer crisis
EluRyng and EnilloRing are bioequivalent substitutes that may be available when Haloette is not
medfinder can locate Haloette (or equivalents) at nearby pharmacies without you having to call each one
For more background on why Haloette can be hard to find, read our related article: Why Is Haloette So Hard to Find? [Explained for 2026]
Frequently Asked Questions
No. As of 2026, Haloette is not on the FDA Drug Shortages Database or the ASHP shortage list. There is no declared national or manufacturer-level shortage. However, individual pharmacies may be out of stock due to local stocking patterns.
Haloette received FDA approval in 2022 as a generic of NuvaRing, manufactured by Mayne Pharma in partnership with Mithra. It is one of three FDA-approved generic versions of NuvaRing, along with EluRyng (2019) and EnilloRing.
There have been isolated supply disruptions for etonogestrel/ethinyl estradiol vaginal rings at the pharmacy level, but no major declared national shortage. The introduction of multiple generics since 2019 has significantly improved overall supply resilience.
Ask your pharmacist if they have EluRyng or EnilloRing (bioequivalent generics), request that they order Haloette from their wholesaler (typically 1-2 business days), or use medfinder to find a nearby pharmacy that has it in stock.
No. Skipping your ring for more than the normal 7-day ring-free interval can leave you unprotected against pregnancy. Talk to your provider about a temporary contraceptive bridge (such as a pill) if you cannot find Haloette or an equivalent ring in time.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Haloette also looked for:
More about Haloette
37,283 have already found their meds with Medfinder.
Start your search today.





